Novo Nordisk has received the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) approval for the Rybelsus (oral semaglutide) label update. The label will now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results